Making good on its threat, Eli Lilly has begun eliminating mandated price breaks to a few dozen hospitals that participate in a federal drug discount program.

The FDA said it will allow Colorado to import certain prescription drugs from Canada in an effort to bring prices down for residents.

The FDA said it will allow Colorado to import certain prescription drugs from Canada in an effort to bring prices down for residents.

After July 1, Medicare will offer GLP-1 weight-loss drugs for $50. It's supposed to be temporary, but chances are it won't be.

In Europe, two divergent paths are emerging as countries grapple with what to do about drug prices, affecting both pharma and patients — and testing the influence of the U.S.

Eli Lilly has told more than 1,000 hospitals participating in the 340B drug discount program to submit claims data over the next five days — or lose price breaks.

Virginia's governor vetoed a closely watched effort to create an advisory panel to lower prescription drug costs.

Nine states have been pursuing the idea of prescription drug affordability boards. Maryland's board just set limits on the price of Ozempic.

A pair of advocacy groups is threatening legal action unless the U.K. government revokes regulations at the heart of a new pharma trade agreement with the U.S.

Capricor Therapeutics has accused Nippon Shinyaku and its U.S. subsidiary of botching the rollout of a Duchenne muscular dystrophy treatment.

Labor Department leadership says the goal is to improve drug pricing transparency, as well as promote cost savings.

Administration report on most-favored nation drug pricing raises new details — and questions.

Committee members largely blamed the other party’s health care policies for driving U.S. health care prices to levels inaccessible to many Americans.

A multiple sclerosis drug from Sanofi that was rejected late last year by the FDA found a warmer reception in Europe.

Legislators in two states are resisting efforts to restrict prescription drug affordability boards.

The board will now oversee a process to lower the cost of the type 2 diabetes medicine Jardiance by January 2027.

Resarchers say Merck should 'urgently begin licensing generic production to its HIV prevention pill.

A bill moving through the Colorado legislature would exempt orphan drugs from pricing caps that might be pursued by the state.

Lenacapavir could put the end of the HIV epidemic in reach — if the people who need it can access it. Here’s one way to make that happen.

The Trump administration is negotiating new drug-pricing deals, now with smaller companies, according to three people with knowledge of the meetings.

After GSK replaced a popular asthma inhaler with an identical product at a higher price, families reported substantial financial and treatment problems, according to a new report.

The patent wall is starting to crack.

Generic versions of Novo Nordisk’s Wegovy and Ozempic medications could be mass produced for about $3 per person a month, according to a new analysis.

As states try to contain the cost of prescription drugs, Virginia lawmakers are pushing an affordability board they believe will go further than efforts in other states.

President Trump's demand that wealthy countries in Europe spend more on drugs so the U.S. can pay less has introduced uncertainty across the continent.

SEC filings show that, at least for some drugmakers, "most-favored nation" drug pricing deals with President Trump last three years.

Public Citizen contends that Novo Nordisk and Eli Lilly's obesity drugs are straining budgets so much that generics should be authorized.

Advocacy groups from 30 countries are urging Merck to create a global access strategy for its once-a-month HIV prevention pill that is still in clinical trials.

As President Trump hails pricing agreements with the pharmaceutical industry, some biotech companies are worried they have been left out in the cold.

The Trump administration is attempting another pilot program that would alter payments for medicines purchased through a controversial federal drug discount program.